It developed to maintain type 2 diabetes
In 2021, we developed 2-(2-cholesteroxyethoxyl)ethyl-3- S -glutathionylpropionate (COXP) as a brain targeting agent [52]
The body more readily absorbs NAC compared to oral glutathione
It is produced in excess in active CD and RCD by enterocytes and lamina propria mononuclear cells thereby preventing elimination of activated intraepithelial lymphocytes (IELs) by exerting anti-apoptotic effect (Malamut et al
GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro)GLP-1s Approved in Europe (Wegovy, Saxenda, Mounjaro) Several GLP-1 medicines are now approved in Europe to help with weight management
Clinical Evidence, Risks, and Future Directions Peptide therapy has shown promise for energy restoration after exercise, but research continues on its safety and practical application